Clinical trials are run at the Vancouver Prostate Centre and at our partner institution, the BC Cancer Agency. To learn more about prostate cancer trials and other GU cancer trials visit the BC Cancer Agency website. In addition, VCHRI has a searchable database of clinical trials at VCH.
A list of clinical trials that are currently recruiting patients at the Vancouver Prostate Centre are outlined below. You can click on the links for detailed information where you’ll be taken to a registry federally and privately supported clinical trials conducted in Canada, the United States, and around the world. These websites give you information about a trial's purpose, who may participate, locations, and phone numbers for more details.
Note, this information should be used in conjunction with advice from health care professionals. Patients must be referred by their physician to be able to participate in a clinical trial.
RADICAL-PC: a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer - click here for more info
A Multicentre Cohort Study of Patients with Advanced Prostate Cancer in Canada-GURC Cohort Study - click here for more info
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study - click here for more info
Canary Prostate Active Surveillance Study (PASS) - click here for more info
Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study - click here for more info
A Phase III Multi-centre Open-label Randomized Controlled Trial of Multi-parametric Magnetic Resonance Imaging (MRI)-Targeted Biopsy Compared to Systematic Trans-rectal Ultrasound (TRUS) Guided Biopsy - click here for more info
Ongoing, not recruiting patients:
HERO: A Multinational Phase 3 Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer - click here for more info
A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer - click here for more info
A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (MDV3100-14) - click here for more info
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer - click here for more info
A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer – NCIC CTG PRC.3/CALGB 90203 - click here for more info
A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) - click here for more info
A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) - click here for more info
A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy - click here for more info
A Randomized, Double-blind, Comparative Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Subjects With High-Risk, Metastatic Hormone-naive Prostate Cancer (mHNPC) - click here for more info
A Phase III Surgical Trial to Evaluate the Benefit of a Standard versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer - click here for more info
Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria - click here for more info
Canadian Bladder Cancer Information System (CBCis)
Canadian Kidney Cancer Information System (CKCis) - a database project
The role of MRI in the Management of Retroperitoneal Lymph Node Metastasis in Patients with Testicular Cancer